Cargando…
Gene Therapy for Acquired and Genetic Cholestasis
Cholestatic diseases can be caused by the dysfunction of transporters involved in hepatobiliary circulation. Although pharmacological treatments constitute the current standard of care for these diseases, none are curative, with liver transplantation being the only long-term solution for severe chol...
Autores principales: | Martínez-García, Javier, Molina, Angie, González-Aseguinolaza, Gloria, Weber, Nicholas D., Smerdou, Cristian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220166/ https://www.ncbi.nlm.nih.gov/pubmed/35740260 http://dx.doi.org/10.3390/biomedicines10061238 |
Ejemplares similares
-
Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model
por: Weber, Nicholas D., et al.
Publicado: (2019) -
A minimal bile salt excretory pump promoter allows bile acid-driven physiological regulation of transgene expression from a gene therapy vector
por: Martínez-García, Javier, et al.
Publicado: (2022) -
Immunology and Gene Therapy: Shoulder to Shoulder Into the Fray: International Symposium: Critical Frontiers Between Immunity and Gene Therapy
Pamplona, Spain, 27–28 October 2009
por: Smerdou, Cristian, et al.
Publicado: (2010) -
mRNA and gene editing: Late breaking therapies in liver diseases
por: Zabaleta, Nerea, et al.
Publicado: (2022) -
Novel vectors and approaches for gene therapy in liver diseases
por: Maestro, Sheila, et al.
Publicado: (2021)